COVID-19 Related Cerebrovascular Thromboembolic Complications in Three Young Patients.
COVID
Cerebral infarction
Cerebral venous thrombosis
Stroke
Thromboembolic complications
Journal
Case reports in neurology
ISSN: 1662-680X
Titre abrégé: Case Rep Neurol
Pays: Switzerland
ID NLM: 101517693
Informations de publication
Date de publication:
Historique:
received:
17
07
2020
accepted:
18
08
2020
entrez:
11
11
2020
pubmed:
12
11
2020
medline:
12
11
2020
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) is a viral illness, caused by the novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). It is currently affecting millions of people worldwide and is associated with coagulopathy, both in the venous and arterial systems. The proposed mechanism being excessive inflammation, platelet activation, endothelial dysfunction, and stasis. As an ongoing pandemic declared by WHO in March 2020, health systems worldwide are experiencing significant challenges with COVID-19-related complications. It has been noticed that patients with COVID-19 are at greater risk of thrombosis.
Identifiants
pubmed: 33173491
doi: 10.1159/000511179
pii: crn-0012-0321
pmc: PMC7573918
doi:
Types de publication
Case Reports
Langues
eng
Pagination
321-328Informations de copyright
Copyright © 2020 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
N Engl J Med. 2011 Sep 15;365(11):993-1003
pubmed: 21899409
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
J Thromb Haemost. 2020 Aug;18(8):2031-2033
pubmed: 32464707
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Cerebrovasc Dis. 2020;49(4):451-458
pubmed: 32690850
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
J Clin Med. 2020 May 11;9(5):
pubmed: 32403217